Penumbra, Inc Net Income (Loss) Available to Common Stockholders, Basic
Penumbra, Inc (PEN) reported Net Income (Loss) Available to Common Stockholders, Basic of $13.38 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-07.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2018-08-07
- Penumbra, Inc net income (loss) available to common stockholders, basic for the quarter ending 2018-06-30 was $13.38M.
- Penumbra, Inc net income (loss) available to common stockholders, basic for the quarter ending 2018-03-31 was $5.49M.
- Penumbra, Inc net income (loss) available to common stockholders, basic for the quarter ending 2017-12-31 was $9.08M.
- Penumbra, Inc net income (loss) available to common stockholders, basic for the quarter ending 2017-09-30 was $238.00K, a 98.00% decline year-over-year.
- Penumbra, Inc net income (loss) available to common stockholders, basic for fiscal 2017 was $4.66M, a 68.56% decline from fiscal 2016.
- Penumbra, Inc net income (loss) available to common stockholders, basic for fiscal 2016 was $14.81M, a 1266.61% increase from fiscal 2015.
- Penumbra, Inc net income (loss) available to common stockholders, basic for fiscal 2015 was $1.08M.
- Penumbra, Inc net income (loss) available to common stockholders, basic for fiscal 2014 was -$833.00K, a 193.91% decline from fiscal 2013.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2018-06-30 | $13.38M 10-Q · filed 2018-08-07 | $18.87M 10-Q · filed 2018-08-07 | $27.95M derived: sum of 3 quarters · filed 2018-08-07 | $28.19M derived: sum of 4 quarters · filed 2018-08-07 | |||
| 2018-03-31 | $5.49M 10-Q · filed 2018-05-08 | $14.57M derived: sum of 2 quarters · filed 2018-05-08 | $14.81M derived: sum of 3 quarters · filed 2018-05-08 | $13.25M derived: sum of 4 quarters · filed 2018-08-07 | |||
| 2017-12-31 | $9.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $9.32M derived: sum of 2 quarters · filed 2018-02-27 | $7.76M derived: sum of 3 quarters · filed 2018-08-07 | $4.66M 10-K · filed 2018-02-27 | |||
| 2017-09-30 | $238.00K 10-Q · filed 2017-11-07 | -$1.32M derived: sum of 2 quarters · filed 2018-08-07 | -$4.43M 10-Q · filed 2017-11-07 | -$6.82M derived: sum of 4 quarters · filed 2018-08-07 | |||
| 2017-06-30 | -$1.56M 10-Q · filed 2018-08-07 | -$4.66M 10-Q · filed 2018-08-07 | -$7.06M derived: sum of 3 quarters · filed 2018-08-07 | $4.85M derived: sum of 4 quarters · filed 2018-08-07 | |||
| 2017-03-31 | -$3.11M 10-Q · filed 2018-05-08 | -$5.50M derived: sum of 2 quarters · filed 2018-05-08 | $6.40M derived: sum of 3 quarters · filed 2018-05-08 | $9.42M derived: sum of 4 quarters · filed 2018-05-08 | |||
| 2016-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $9.51M derived: sum of 2 quarters · filed 2018-02-27 | $12.52M derived: sum of 3 quarters · filed 2018-02-27 | $14.81M 10-K · filed 2018-02-27 | |||
| 2016-09-30 | $11.91M 10-Q · filed 2017-11-07 | -$1.11M 10-Q · filed 2016-11-03 | $14.92M derived: sum of 2 quarters · filed 2017-11-07 | $17.21M 10-Q · filed 2017-11-07 | -$141.00K 10-Q · filed 2016-11-03 | $18.84M derived: sum of 4 quarters · filed 2017-11-07 | |
| 2016-06-30 | $3.01M 10-Q · filed 2017-08-08 | $185.00K 10-Q · filed 2016-08-09 | $5.30M 10-Q · filed 2017-08-08 | $965.00K 10-Q · filed 2016-08-09 | $6.94M derived: sum of 3 quarters · filed 2017-08-08 | $7.21M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | $2.29M 10-Q · filed 2017-05-09 | $780.00K 10-Q · filed 2016-05-09 | $3.92M derived: sum of 2 quarters · filed 2017-05-09 | $4.20M derived: sum of 3 quarters · filed 2017-05-09 | $3.65M derived: sum of 4 quarters · filed 2017-05-09 | ||
| 2015-12-31 | $1.63M 10-K · filed 2017-02-28 | $1.91M derived: sum of 2 quarters · filed 2017-02-28 | $1.36M derived: sum of 3 quarters · filed 2017-02-28 | $1.08M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | $276.00K 10-K · filed 2017-02-28 | -$277.00K derived: sum of 2 quarters · filed 2017-02-28 | $175.00K 10-Q · filed 2016-11-03 | $307.00K derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | -$553.00K 10-K · filed 2017-02-28 | -$34.00K 10-Q · filed 2016-08-09 | $31.00K derived: sum of 3 quarters · filed 2017-02-28 | -$1.16M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | $503.00K 10-K · filed 2017-02-28 | $584.00K derived: sum of 2 quarters · filed 2017-02-28 | -$608.00K derived: sum of 3 quarters · filed 2017-02-28 | -$527.00K derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | $81.00K 10-K · filed 2016-03-08 | -$1.11M derived: sum of 2 quarters · filed 2016-03-08 | -$1.03M derived: sum of 3 quarters · filed 2016-03-08 | -$833.00K 10-K · filed 2017-02-28 | |||
| 2014-09-30 | -$1.19M 10-K · filed 2016-03-08 | -$1.11M derived: sum of 2 quarters · filed 2016-03-08 | -$933.00K 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | $81.00K 10-K · filed 2016-03-08 | $361.00K derived: sum of 2 quarters · filed 2016-03-08 | |||||
| 2014-03-31 | $280.00K 10-K · filed 2016-03-08 | ||||||
| 2013-12-31 | $887.00K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |